Fresenius Kabi Pharmaceuticals Holding Inc. (APCVZ) Subsidiary Gets OK from FDA to Market Oncology Product
APP Pharmaceuticals Inc. is a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding Inc. focused on the development, manufacture and marketing of injectable pharmaceutical products for the oncology, anti-infective, anesthetic and critical care markets. The company today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection. The company said it plans to launch the product immediately and anticipates expanding its position in the oncology arena. Topotecan for Injection is indicated for use in small cell lung cancer sensitive disease when the first-line of chemotherapy has failed. It has also received clearance…